These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
654 related articles for article (PubMed ID: 15635596)
1. Neoadjuvant chemotherapy in breast cancer. Charfare H; Limongelli S; Purushotham AD Br J Surg; 2005 Jan; 92(1):14-23. PubMed ID: 15635596 [TBL] [Abstract][Full Text] [Related]
2. [Neoadjuvant Chemotherapy in breast cancer]. Suzuki E; Toi M Nihon Rinsho; 2006 Mar; 64(3):536-9. PubMed ID: 16529046 [TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy in stage III breast cancer. Alassas M; Chu Q; Burton G; Ampil F; Mizell J; Li BD Am Surg; 2005 Jun; 71(6):487-92. PubMed ID: 16044927 [TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy for local advanced breast cancer with stage IIIB. Kim R; Osaki A; Tanabe K; Toge T Oncol Rep; 2004 Jun; 11(6):1265-72. PubMed ID: 15138565 [TBL] [Abstract][Full Text] [Related]
5. Recurrence rates after DCE-MRI image guided planning for breast-conserving surgery following neoadjuvant chemotherapy for locally advanced breast cancer patients. Garimella V; Qutob O; Fox JN; Long ED; Chaturvedi A; Turnbull LW; Drew PJ Eur J Surg Oncol; 2007 Mar; 33(2):157-61. PubMed ID: 17085007 [TBL] [Abstract][Full Text] [Related]
6. Breast-conserving surgery in the neoadjuvant setting. Brenin DR; Morrow M Semin Oncol; 1998 Apr; 25(2 Suppl 3):13-8. PubMed ID: 9566202 [TBL] [Abstract][Full Text] [Related]
8. Breast-conserving therapy after neoadjuvant chemotherapy: long-term results. Beriwal S; Schwartz GF; Komarnicky L; Garcia-Young JA Breast J; 2006; 12(2):159-64. PubMed ID: 16509842 [TBL] [Abstract][Full Text] [Related]
9. Sentinel node biopsy before neoadjuvant chemotherapy for determining axillary status and treatment prognosis in locally advanced breast cancer. Cox CE; Cox JM; White LB; Stowell NG; Clark JD; Allred N; Meyers M; Dupont E; Furman B; Minton S Ann Surg Oncol; 2006 Apr; 13(4):483-90. PubMed ID: 16523361 [TBL] [Abstract][Full Text] [Related]
10. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy. Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948 [TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy for locally advanced breast cancer results in alterations in preoperative tumor marker status. Piper GL; Patel NA; Patel JA; Malay MB; Julian TB Am Surg; 2004 Dec; 70(12):1103-6. PubMed ID: 15663054 [TBL] [Abstract][Full Text] [Related]
12. Future prospects of neoadjuvant chemotherapy in treatment of primary breast cancer. Wang HC; Lo SS Semin Surg Oncol; 1996; 12(1):59-66. PubMed ID: 8821411 [TBL] [Abstract][Full Text] [Related]
13. Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy. Huang EH; Tucker SL; Strom EA; McNeese MD; Kuerer HM; Hortobagyi GN; Buzdar AU; Valero V; Perkins GH; Schechter NR; Hunt KK; Sahin AA; Buchholz TA Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):351-7. PubMed ID: 15890574 [TBL] [Abstract][Full Text] [Related]
14. [New combination chemotherapy regimens in the primary treatment of operable breast cancer]. Conti F; Sergi D; Foggi P; Abbate MI; Lopez M Clin Ter; 2007; 158(1):55-75. PubMed ID: 17405660 [TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy for early breast cancer. Mieog JS; van de Velde CJ Expert Opin Pharmacother; 2009 Jun; 10(9):1423-34. PubMed ID: 19505212 [TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy for locally advanced breast cancer: a review of the literature and future directions. Mathew J; Asgeirsson KS; Cheung KL; Chan S; Dahda A; Robertson JF Eur J Surg Oncol; 2009 Feb; 35(2):113-22. PubMed ID: 18502088 [TBL] [Abstract][Full Text] [Related]
17. [Breast cancer]. Kobayashi T; Yamazaki H; Nakamura T; Ogihara A; Fujii T; Hirano A; Uno S; Yoshida K; Nagata T; Uchida K; Kubo H; Tozaki M; Kanehira C; Miyazawa Y; Suzuki M; Kuraishi Y Gan To Kagaku Ryoho; 2001 Nov; 28(12):1814-25. PubMed ID: 11729473 [TBL] [Abstract][Full Text] [Related]
18. [Neoadjuvant systemic therapy in patients with operable primary breast cancer: more benefits than breast-conserving therapy]. Straver ME; van Adrichem JC; Rutgers EJ; Rodenhuis S; Linn SC; Loo CE; Gilhuijs KG; Oldenburg HS; Wesseling J; Russell NS; Antonini N; Vrancken Peeters MT Ned Tijdschr Geneeskd; 2008 Nov; 152(46):2519-25. PubMed ID: 19055260 [TBL] [Abstract][Full Text] [Related]
19. Breast conservation after neoadjuvant chemotherapy for stage II carcinoma of the breast. Schwartz GF; Meltzer AJ; Lucarelli EA; Cantor JP; Curcillo PG J Am Coll Surg; 2005 Sep; 201(3):327-34. PubMed ID: 16125064 [TBL] [Abstract][Full Text] [Related]
20. The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapy. Peintinger F; Symmans WF; Gonzalez-Angulo AM; Boughey JC; Buzdar AU; Yu TK; Hunt KK; Singletary SE; Babiera GV; Lucci A; Meric-Bernstam F; Kuerer HM Cancer; 2006 Sep; 107(6):1248-54. PubMed ID: 16862596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]